Bml Capital Management, LLC / ANTX
Bml Capital Management, LLC’s An2 Therapeutics Inc Position
Does Bml Capital Management, LLC own An2 Therapeutics Inc (ANTX)? Not currently — the last reported position was 5.75M shares worth $8M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$8M
Q1 2025
Shares
5.75M
% of Portfolio
+6.33%
Quarters Held
3
position exited
Position History ANTX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bml Capital Management, LLC’s full portfolio or all institutional holders of ANTX.